Non-invasive Brain Stimulation for Dementia Symptoms
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases
Recruiting
N/AInterventional Study
Alzheimer DiseaseFrontotemporal DementiaDementia With Lewy Bodies
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
200 (estimated)
Sponsor
Kuopio University Hospital · Other
Who this trial is looking for
This trial is looking for people with mild cognitive issues or specific types of dementia. Participants will receive non-invasive brain stimulation to see if it helps improve their symptoms.
Are You a Good Fit for This Trial?
You may be able to join if
I have mild cognitive impairment due to Alzheimer's disease
I have dementia with Lewy bodies
I have frontotemporal dementia
I have idiopathic normal pressure hydrocephalus
You may not be able to join if
I have a history of seizures
I am pregnant
I have metal implants in my head
I have electronic implants like a pacemaker
I am under 18 years old
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease,…
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Mild Cognitive Impairment due to Alzheimer's disease
* Dementia with Lewy Bodies
* Frontotemporal dementia
* Idiopathic normal pressure hydrocephalus (iNPH)
Exclusion Criteria:
* History of seizures
* Pregnancy
* Metal implants in the head (except dental fillings)
* Electron…
Inclusion Criteria:
* Mild Cognitive Impairment due to Alzheimer's disease
* Dementia with Lewy Bodies
* Frontotemporal dementia
* Idiopathic normal pressure hydrocephalus (iNPH)
Exclusion Criteria:
* History of seizures
* Pregnancy
* Metal implants in the head (except dental fillings)
* Electronic implants (i.e. pace-maker, implanted medical pump)
* Age \<18 years
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.